Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma

Published:2020-07 Issue: Volume:106 Page:104704
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Qin Guanjie,Rai Raju,Zhang Rongjun,Su Yixin,Zhang Bin,Pan Yuefei,Xiong Ruihua,Xie Yuan,Yang Huiyun,Kong Xiangyun,Luo Zan,Ruan Xiaolan,Mo Yunyan,Aftab Omer,Shahisanjeev ,Jazib ,Jiang Wei^ORCID

Funder

National Natural Science Foundation of China

Scientific Research and Technology Development Program of Guilin

Natural Science Foundation of Guangxi

Natural Science Foundation Key Projects of Guangxi

Key Research and Development Program of Guangxi

Scientific Research Program of the Health Commission of Guangxi Zhuang Autonomous Region

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference26 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Current management of nasopharyngeal cancer;Lee;Semin Radiat Oncol,2012

3. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis;Blanchard;Lancet Oncol,2015

4. What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis;Ribassin-Majed;J Clin Oncol,2017

5. Guidelines insights: head and neck cancers, version 1.2018;Colevas;J Natl Compr Canc Netw,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent chemotherapy using taxane plus cisplatin versus cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy;Therapeutic Advances in Medical Oncology;2023-01